Clinical Trial Update: Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome [Phase 4]

View source ↗

Summary

This ClinicalTrials.gov update confirms the completion and results posting of a Phase 4 study evaluating Reyataz (atazanavir) in HIV-infected patients with HIV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Lipodystrophy Syndrome

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV-Associated Lipodystrophy Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2010-05-07